Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
  1. 4 Shares withheld for taxes Chief Legal Officer gave up 7,893 shares (to pay taxes)
  2. 4 Planned sale President and CEO sold 45,000 shares at $19.69 ($885,825)
  3. 4 Grant or award Director acquired 3,486 shares (grant or award)
  4. 4 Grant or award Director acquired 3,486 shares (grant or award)
  5. 4 Grant or award Director acquired 3,486 shares (grant or award)
  6. 4 Grant or award Director acquired 3,486 shares (grant or award)
  7. 4 Grant or award Director acquired 3,486 shares (grant or award)
  8. 4 Grant or award Director acquired 3,486 shares (grant or award)
  9. 4 Grant or award Director acquired 3,486 shares (grant or award)
  10. 4 Grant or award Director acquired 3,486 shares (grant or award)
  11. 4 Exercise or conversion Chief Financial Officer acquired 35,000 shares (option exercise)
  12. 4 Shares withheld for taxes Chief Financial Officer gave up 1,333 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Oper. & Tech. Officer gave up 2,076 shares (to pay taxes)
  14. 4 Open-market sale Chief Medical Officer sold 3,138 shares at $22.17 ($69,559)
  15. 4 Shares withheld for taxes Chief Scientific Officer gave up 2,058 shares (to pay taxes)
  16. 4 Shares withheld for taxes President and CEO gave up 9,308 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Legal Officer gave up 1,843 shares (to pay taxes)
  18. 4 Open-market sale Chief Financial Officer sold 2,400 shares at $30.24 ($72,573)
  19. 4 Open-market sale Chief Financial Officer sold 17,680 shares at an average $35.18 ($622,035)
  20. 4 Open-market sale Chief Financial Officer sold 2,400 shares at $31.26 ($75,012)

Page 6 of 22 · 435 filings